Screener
BioSig Technologies, Inc. STEX Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 20.2×+20.2× | 13.9×+11.5× | 1.7×+1.5× | 0.1×-0.4× | 0×-0.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×— | —— | 0.3×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $0.80+713% | $0.91+627% | $2.78+2,624% | -$0.21-735% | -$0.13-26,000% | |
| Valuation | ||||||
| Market capitalization | $90.06M-46.6% | $103.41M+623% | $123.64M+381% | $203.16M+4,526% | $1.13B+24,967% | |
| Price / book | 0.6×— | 0.7×-4.8× | 0.9×— | —— | —— |
FAQ
- What are BioSig Technologies, Inc.'s profit margins?
- BioSig Technologies, Inc. (STEX) runs a 80.1% gross margin and a -32155.0% operating margin, with a -25825.0% net margin.
- Where do BioSig Technologies, Inc.'s ratios come from?
- Every ratio is computed from BioSig Technologies, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
